Target intelligence / Profile preview

Ribosomal protein L9 pseudogene 18 (RPL9P18)

Target: RPL9P18
Molecular classification: Other, Pseudogene

Overview

Ribosomal protein L9 pseudogene 18 (RPL9P18) is a non-functional genomic sequence in humans that arose from duplication and divergence of the ribosomal protein L9 gene (RPL9). Unlike the parent gene, RPL9P18 generally contains disabling mutations that prevent it from encoding a functional protein. Such pseudogenes are common in the ribosomal protein gene family and serve no known biological or disease role, nor are they relevant as drug targets or biomarkers

Other names: RPL9_6_709Ribosomal protein L9 pseudogene 18RPL9P18

Mechanism of action

None

Biological functions

None

Disease associations

None

Safety considerations

None

Interacting drugs

None

Biomarkers

None

Beyond the preview

Go deeper on Ribosomal protein L9 pseudogene 18 (RPL9P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L9 pseudogene 18 (RPL9P18).

Explore the full profile